(February 25, 2021) Session 1: Introducing NGB-R, a Disruptive 4D Bioprinting System from Poietis
Watch this webinar to learn more about a state-of-the-art, one-of-a-kind, disruptive 4D bioprinting technology from Poietis. Focusing on a cytocentric approach, tissues grow in a more natural environment, leading to proper morphogenesis and predictable biological processes, including cell differentiation, migration, multiplication, and metabolic processes.
The NGB-R platform integrates automation and robotics, numerous online sensors, and Artificial Intelligence processing. In addition, it integrates all bioprinting techniques (laser-assisted bioprinting, bioextrusion, and micro-valve bioprinting), a world’s first in the bioprinting market.
This was the first of a 3-part series that provided an introduction and overview to the technology, a survey of various 4D bioprinting applications, and a live hands-on demonstration of the hardware and software.”
In this first of three sessions in this series, we introduced the NGB-R system and delve more into the idea of disruptive 4D bioprinting technology – focusing on the cytocentric approach which allows tissues to grow in a more natural environment, leading to proper morphogenesis and predictable biological processes including cell differentiation, migration, multiplication and metabolic processes.
We reviewed the features and benefits of the system, along with the system components. The NGB-R system has been designed for advanced bioprinting applications, including novel laser-assisted bioprinting technology, along with more conventional extrusion and inkjet techniques. Fabrication plans can include any combination of all three techniques to ensure optimal design and patterning of cells, bioinks, and extracellular matrix compounds
This webinar included a workflow video showing the NGB-R system in action, including the robotic arm, the laser-assisted printing head, as well as the integrated microscope to help visualize the progression of the fabrication process.
A few key examples were shown to highlight full capabilities of the NGB-R system in 4D bioprinting of tissues such as skin.
Watch the second session in this series for a more detailed review of this and other successful applications of the NGB-R system, including pancreatic and liver tissues, brain organoids, as well as cartilaginous tissue. In the third and final session in this series a live virtual demo will be provided showing a detailed overview of both the software and hardware components of the NGB-R system.
About the Speaker (s)
Tonya Coulthard, MSc,
Manager, Imaging Division, Scintica
Tonya Coulthard holds an MSc from the University of British Columbia in Experimental Medicine. Throughout her academic training she focused on a variety of diseases ranging from prions to chronic obstructive pulmonary disorder. In her professional career she has worked with several imaging and medical device companies; in these roles she has interacted with researchers around the world covering a very diverse range of research applications. In her present role at Scintica Instrumentation Tonya manages our Imaging Division; in this role she works in supporting our customers in understanding the products offered and how these instruments help to meet their research needs
Sales Manager, Poietis
Antoine is an accomplished Sales Manager professional with 7+ years’ experience in the biotech industry and a strong background in both international business development and worldwide distribution network management. He joined Poietis in 2019, a biotech company specialized in advanced 4D bioprinting solutions for translational and clinical research.
Antoine studied in France, Spain and the United Kingdom. In 2012, he graduated as valedictorian of his class at the American Business School of Paris. Before joining Poietis, Antoine worked for over 4 years as an International Sales Manager for a British-based bio-molecular imaging system manufacturer in the Life Science industry. He has traveled extensively and is fluent in French, English and Spanish.
Dr. Mikael Garcia,
Business Application Manager, Poietis
Mikael has over 10 years’ experience in the field of biotechnologies. He holds a PhD in Biology through a CIFRE fellowship between the University of Bordeaux and the company Cytoo, a biotech specialized in the development of physiologically relevant cellular models and assays for High Content Screening. With a strong multidisciplinary background in the fields of behavioral pharmacology, neurobiology, cell micro patterning and high-resolution microscopy, he joined Poietis over 5 years ago. As a Business Application Manager, he leads Industrial and European projects for the development of alternative human tissue models through 3D Bioprinting (Hair Follicle, Skin, Brain, Pancreas…) and supervises a team of Application Engineers working on proof-of-concept studies with the NGB-R bioprinting platform.